Results 11 to 20 of about 12,518 (225)

Mechanisms of Primary Membranous Nephropathy [PDF]

Biomolecules, 2021
Membranous nephropathy (MN) is an autoimmune disease of the kidney glomerulus and one of the leading causes of nephrotic syndrome. The disease exhibits heterogenous outcomes with approximately 30% of cases progressing to end-stage renal disease.
Yan Gu, Hui Xu, Damu Tang
doaj   +3 more sources

Primary Membranous Nephropathy with Crescents

Indian Journal of Kidney Diseases, 2023
We present the case of a 46-year-old patient with a history of hypertension, renal biopsy-proven primary membranous nephropathy, and a unique progression. He initially presented with edema and hypertension.
Megana Sunder, Balagurunathan Raghavan, Saravanan Margabandhu   +2 more
doaj   +2 more sources

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy

Frontiers in Immunology, 2022
Primary membranous nephropathy (pMN) is an auto-immune disease characterized by auto-antibodies targeting podocyte antigens resulting in activation of complement and damage to the glomerular basement membrane.
Maxime Teisseyre, Maxime Teisseyre, Marion Cremoni, Marion Cremoni, Sonia Boyer-Suavet, Caroline Ruetsch, Daisy Graça, Daisy Graça, Vincent L. M. Esnault, Vincent L. M. Esnault, Vesna Brglez, Vesna Brglez, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski, Barbara Seitz-Polski   +15 more
doaj   +3 more sources

Primary membranous nephropathy with concomitant IgA nephropathy

Saudi Journal of Kidney Diseases and Transplantation, 2019
Membranous nephropathy (MN), an autoimmune glomerulonephritis which can occur in primary and secondary forms, is one of the most common inflammatory glomerulopathies in elderly patients.
Reza Khorsan, Ramy M Hanna, Khalid Ameen, Farid Arman, Niloofar Nobakht, Huma Hasnain, Ashley Hyunh, Anjay Rastogi   +7 more
doaj   +3 more sources

Editorial: Primary membranous nephropathy

Frontiers in Immunology, 2022
Maria Infantino
doaj   +3 more sources

Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy. [PDF]

Kidney Int Rep
Povetacicept is an inhibitor of B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), 2 cytokines central to the pathogenesis of autoimmune glomerulonephritis. Both BAFF and APRIL promote B-cell and plasma cell survival and function.
Madan A, Yalavarthy R, Kim DK, Moon JY, Park I, Mandayam S, Cortazar F, Kim SG, Enstrom A, Thomas H, Li J, Peng SL, Chen YC, Sanders J, Egbuna O, Tumlin J, AIS-D03 RUBY-3 Study Group.   +16 more
europepmc   +4 more sources

Establishing a differential diagnosis model between primary membranous nephropathy and non-primary membranous nephropathy by machine learning algorithms

Renal Failure
Context Four algorithms with relatively balanced complexity and accuracy in deep learning classification algorithm were selected for differential diagnosis of primary membranous nephropathy (PMN).Objective This study explored the most suitable ...
Shangmei Cao, Shaozhe Yang, Bolin Chen, Xixia Chen, Xiuhong Fu, Shuifu Tang   +5 more
doaj   +3 more sources

A cohort study of membranous nephropathy, primary or secondary [PDF]

BMC Nephrology, 2021
Abstract Background Although IgG4 deposit against phospholipase A2 receptor (anti-PLA2R) is predominantly presented in the renal biopsy of patients with primary membranous nephropathy (MN), its diagnostic value of this immune complex has not been fully established.
Maryam Arghiani, Boshra Hasan Zamani, Fatemeh Nazemian, Sara Samadi, Malihe Saber Afsharian, Mahmoud Habibzadeh, Saeid Eslami, Mahin Ghorban Sabbagh   +7 more
openaire   +3 more sources

Choroidal Neovascularization in Primary Membranous Nephropathy

American Journal of Case Reports, 2020
BACKGROUND We describe the retinal findings in a patient affected by primary membranous nephropathy (MN). CASE REPORT A 61-year-old man presented with a 3-month history of metamorphopsia and decreased visual acuity in both eyes. He was affected by nephrotic syndrome in primary MN and treated with systemic corticosteroids.
Gambato T., Francescutti L., Lanzetta P.
openaire   +4 more sources

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy

BMC Nephrology, 2020
Background The kidney is a major target in primary antiphospholipid syndrome. Several types of nephropathy have been reported, the most frequent being acute or chronic specific vascular nephropathies and membranous nephropathy.
Maxime Teisseyre, Hélène Perrochia, Pascal Reboul, Sylvain Cariou, Sophie Renaud, Cédric Aglae, Olivier Moranne   +6 more
doaj   +1 more source